Biotechnology News

Fri, 2013-11-08 12:01

WASHINGTON--(BUSINESS WIRE)--BIO's 2013 Pac Rim Summit on Industrial Biotechnology and Bioenergy will feature presentations from executives in the advanced biofuel sector discussing R & D progress and financing challenges.

Fri, 2013-11-08 12:01

BALTIMORE--(BUSINESS WIRE)--Cerecor initiated a Phase 2 study of CERC-301, an oral, selective NR2B antagonist for the adjunctive treatment of subjects with MDD who have not adequately responded to their current therapy.

Fri, 2013-11-08 12:01

ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today the appointment of Paris Panayiotopoulos as President and Managing Director of EMD Serono.

Fri, 2013-11-08 12:01

BUNNIK, The Netherlands & ATLANTA--(BUSINESS WIRE)--AM‐Pharma B.V., a biopharmaceutical company focused on the development of recAP (recombinant human Alkaline Phosphatase) for inflammatory indications, today presents preclinical data on its...

Fri, 2013-11-08 12:01

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa today announced that Neil K. Warma, Opexa’s President and Chief Executive Officer, has been invited as a panel member to participate in the New York CEO Conference.

Fri, 2013-11-08 12:01

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (NASDAQ:ADXS), a leader in developing the next generation of cancer immunotherapies, announced today final 18-month survival data from Lm-LLO-E7-15, a randomized Phase 2 study evaluating the safety...

Fri, 2013-11-08 12:01

CHELSEA, Mass.--(BUSINESS WIRE)--Civitas Therapeutics extents patent protection of lead product to 2032. Receives pharmaceutical composition patent for CVT-301, one of over 115 issued patents worldwide protecting the product.

Fri, 2013-11-08 12:01

SUNNYVALE, Calif.--(BUSINESS WIRE)--Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, will host a conference call and webcast on Friday, November 15, 2013 at 11:00 a.m. Eastern Time to discuss the Company’s third...

Fri, 2013-11-08 12:01

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE® (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) to RAPAMUNE® 3 to 5...

Fri, 2013-11-08 12:01

VANCOUVER, British Columbia--(BUSINESS WIRE)--NRC-IRAP to provide STEMCELL Technologies with up to $1.5 million in financial support for the development of cell isolation technology that will further basic and translational HIV research

Fri, 2013-11-08 12:01

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc., (NASDAQ:OXBT) announces $6 million received from exercise of warrants issued in connection with its July 2013 Series C 8% Convertible Preferred Stock financing.

Fri, 2013-11-08 12:01

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Third Quarter 2013 Financial Results Teleconference and Webcast

Fri, 2013-11-08 12:01

DUBLIN--(BUSINESS WIRE)--Mallinckrodt (NYSE:MNK), a global specialty pharmaceutical and global medical imaging company, will hold an investor briefing on November 14, 2013. The meeting will be held at the Grand Hyatt at 109 East 42nd Street at...

Fri, 2013-11-08 12:01

DUBLIN--(BUSINESS WIRE)--Covidien plc today reported results for the fourth quarter of fiscal 2013 (July - September 2013).

Fri, 2013-11-08 12:01

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals to Present at 2013 Credit Suisse Healthcare Conference

Fri, 2013-11-08 07:00

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: MEDA (STO:MEDAA): January-September 2013 · Group net sales reached SEK 9,664 million (9,796), corresponding to organic growth[1] of 2% compared to last year. · EBITDA amounted to SEK 2,719...

Fri, 2013-11-08 07:00

SAN DIEGO & LEIDEN, Netherlands--(BUSINESS WIRE)--Santarus SNTS and Pharming to present new data for RUCONEST in the treatment of acute angioedema at the American College of Allergy, Asthma & Immunology ACAAI annual meeting in Baltimore...

Fri, 2013-11-08 02:00

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) today announced the pricing of a total offering of $700 million aggregate principal amount of its convertible senior notes, consisting of $350 million aggregate principal amount...

Fri, 2013-11-08 02:00

DENVER--(BUSINESS WIRE)--The Colorado BioScience Association (CBSA) is celebrating its tenth anniversary by conferring three special ten-year Recognition Awards, in addition to presenting its 2013 Industry Awards.

Fri, 2013-11-08 02:00

TORONTO--(BUSINESS WIRE)--Research leaders from Ontario Institute for Cancer Research and UC Santa Cruz, with Sage Bionetworks and IBM’s DREAM, announce an open challenge to develop methods for predicting cancer mutations.

Thu, 2013-11-07 21:00

TORONTO--(BUSINESS WIRE)--Dr John Wallace, Antibe Therapeutics Inc. founder and Chief Scientific Officer awarded the Heymans Foundation Memorial Medal in Ghent, Belgium.

Thu, 2013-11-07 21:00

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals will launch Lomedia™ 24 Fe, its First-to-File generic equivalent for Loestrin® 24 Fe tablets, in early 2014. The product will arrive in pharmacies the first week of January.

Thu, 2013-11-07 21:00

PLYMOUTH, Mich.--(BUSINESS WIRE)--ProNAi Therapeutics, a leader in nucleic acid therapeutics, announced response & safety data from its ongoing Phase II cancer (NHL) study of PNT2258, a novel BCL2 inhibitor, will be presented at ASH.

Thu, 2013-11-07 21:00

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on...

Thu, 2013-11-07 21:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a life sciences company focused on the development and commercialization of novel drug delivery technologies as well as biopolymer devices for the treatment of spinal...

Thu, 2013-11-07 21:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced today that it will host a conference call and live audio webcast at 8:30 a.m. EST on Thursday, November 14, 2013 to report its third quarter 2013 financial...

Thu, 2013-11-07 21:00

SAN DIEGO--(BUSINESS WIRE)--Santarus SNTS 3Q2013 financial results - total revenue of $98.8 million, up 81% vs prior year period. Adjusted earnings of $35.6 million, up 189% vs 3Q2012. Conference call for today cancelled.

Thu, 2013-11-07 21:00

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. today reported financial results for the third quarter ended September 30, 2013 and provided an overview of the Company’s recent corporate developments.

Thu, 2013-11-07 21:00

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2013. Revenues for the third quarter were $2.5 million, compared to $0.4 million for...

Thu, 2013-11-07 21:00

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) today reports its nine month and third quarter 2013 financial results and provides updates on clinical development, commercialization and corporate development activities. Total...

Thu, 2013-11-07 21:00

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc. (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that there will be a poster presentation by Dr. Jorge...

Thu, 2013-11-07 21:00

RALEIGH, N.C. & SAN DIEGO--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Santarus, Inc. (NASDAQ:SNTS) today announced that the companies have entered into a definitive merger agreement under which Salix will acquire all of...

Thu, 2013-11-07 21:00

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) today announced its financial results for the third quarter ended September 30, 2013. “We had an eventful third quarter – we filed an NDA for tavaborole, our most advanced...

Thu, 2013-11-07 21:00

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions reports 2013 3Q and 9 month financial results including strong year-over-year revenue and net income growth; revises full year 2013 guidance to upper end of previous range.

Thu, 2013-11-07 21:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today reported its third quarter 2013 financial results and provided an update on its clinical pipeline. Earlier today, Infinity announced that five abstracts...

Thu, 2013-11-07 21:00

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Steve Gilman, Cubist’s Executive Vice President and Chief Scientific Officer, will present at the Goldman Sachs U.S. Emerging SMID Cap Growth...

Thu, 2013-11-07 16:01

NEW YORK--(BUSINESS WIRE)--The Brain & Behavior Research Foundation Awards $1.5 Million in
NARSAD Distinguished Investigator Grants to Fund Cutting-Edge Research

Thu, 2013-11-07 16:01

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the treatment and management of the neurological...

Thu, 2013-11-07 16:01

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) has received the first $12 million installment from the equity agreement with newly formed Lorem Vascular.

Thu, 2013-11-07 16:01

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that it has dosed the first subject in OPuS-1 (Oral ProphylaxiS-1), a Phase 2a proof of concept clinical trial of orally-administered...

Thu, 2013-11-07 16:01

MEMPHIS, Tenn.--(BUSINESS WIRE)--Ariste Medical receives a second patent relating to its drug eluting polymer for devices made with polytetrafluoroethylene and expanded PTFE helping preserve functions of implantable medical devices.

Thu, 2013-11-07 16:01

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion announced that researchers will present data from clinical studies of Soliris® as a treatment for patients with PNH and aHUS at 55th Annual Meeting of the American Society of Hematology (ASH)

Thu, 2013-11-07 16:01

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the Credit Suisse 2013 Healthcare Conference in Phoenix, Arizona...

Thu, 2013-11-07 11:01

MINNEAPOLIS--(BUSINESS WIRE)--Piper Jaffray announces the hiring of Josh Schimmer, MD as a senior research analyst in its New York office.

Thu, 2013-11-07 11:01

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that two abstracts on its humanized anti-CD37 mono-specific protein therapeutic, otlertuzumab (TRU-016), being evaluated in patients with chronic lymphocytic...

Thu, 2013-11-07 11:01

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. announced today plans to present at the 2013 American Society of Hematology (ASH) Annual Meeting and Exposition, highlighting study data of the company’s lead drug candidate, rivipansel...

Thu, 2013-11-07 11:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals to Present Preclinical Research at the 2013 American Society of Hematology Annual Meeting

Thu, 2013-11-07 11:01

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced the pricing of an underwritten public offering of 4.5 million shares of its common stock at a price of $10.00 per share, less underwriting discounts...

Thu, 2013-11-07 11:01

BOUDRY, Switzerland--(BUSINESS WIRE)--MM-020 accepted for plenary presentation at American Society of Hematology annual meeting